Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
The T-win® technology: immune-modulating vaccines
Mads Hald Andersen
Center for Cancer Immune Therapy (CCIT)
25
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The T-win® technology: immune-modulating vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Immunocompetent Cell
100%
Tumor Microenvironment
100%
Indoleamine 2,3 Dioxygenase
100%
Programmed Death 1 Ligand 1
100%
Neoplasm
50%
Human Leukocyte Antigen
50%
Clinical Trial
50%
Inflammatory Cell
50%
T Cell
50%
Epitope
50%
T-Cell Response
50%
Regulatory T Cell
50%
CD8 Antigen
50%
Tumor Antigen
50%
Antigen Expression
50%
Tryptophan
50%
Effector Cell
50%
Arginase
50%
Dioxygenase
50%
Keyphrases
Immune Regulation
100%
Anti-Tregs
100%
Tumor Microenvironment
50%
Indoleamine 2,3-dioxygenase 1 (IDO1)
50%
Programmed Death-ligand 1 (PD-L1)
50%
Regulatory Immune Cells
50%
Human Leukocyte Antigen
25%
Clinical Trials
25%
Stable Cell Line
25%
Inflammatory Cells
25%
T Cells
25%
Vaccination
25%
Peptide Epitopes
25%
Tumor Antigen
25%
Regulatory Cells
25%
CD-8
25%
Therapeutic Vaccination
25%
Inhibitory Pathways
25%
Antigen Expression
25%
Malignant Cells
25%
Effector Cells
25%
Long Peptides
25%
Dioxygenase
25%
Anti-regulatory T Cells
25%
Arginase
25%
Tryptophan 2
25%
Regulatory Environment
25%
Inflammatory Milieu
25%
Anti-tumor T Cell Response
25%
Immunology and Microbiology
Vaccine Efficacy
100%
Regulatory T Cell
100%
Immunocompetent Cell
40%
T Cell
40%
Vaccination Policy
40%
Indoleamine 2,3-dioxygenase
40%
Programmed Death 1 Ligand 1
40%
Human Leukocyte Antigen
20%
CD4
20%
Epitope
20%
CD8
20%
Tumor Antigen
20%
Inflammatory Cell
20%
Antigen Expression
20%
Effector Cell
20%